Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma.

[1]  H. Hakonarson,et al.  Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma , 2012, Nature Genetics.

[2]  P. Branchereau,et al.  GABAA Receptor and Glycine Receptor Activation by Paracrine/Autocrine Release of Endogenous Agonists: More Than a Simple Communication Pathway , 2011, Molecular Neurobiology.

[3]  Joseph T. Glessner,et al.  Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci , 2011, PLoS genetics.

[4]  Nazneen Rahman,et al.  Integrative genomics identifies LMO1 as a neuroblastoma oncogene , 2011, Nature.

[5]  D. Pomp,et al.  Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression , 2010, Clinical & Experimental Metastasis.

[6]  J. Rachmilewitz,et al.  Human Embryonic Stem Cells Suppress T Cell Responses via Arginase I-Dependent Mechanism , 2009, The Journal of Immunology.

[7]  Nazneen Rahman,et al.  Common variations in BARD1 influence susceptibility to high-risk neuroblastoma , 2009, Nature Genetics.

[8]  Xia Yang,et al.  Validation of Candidate Causal Genes for Abdominal Obesity Which Affect Shared Metabolic Pathways and Networks , 2009, Nature Genetics.

[9]  Hiroki Nagase,et al.  Genetic architecture of murine skin inflammation and tumor susceptibility , 2016 .

[10]  D. Koomoa,et al.  Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma. , 2008, Cancer research.

[11]  B. Berwin,et al.  Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression. , 2008, Molecular immunology.

[12]  W. London,et al.  ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. , 2008, Cancer research.

[13]  Gudrun Schleiermacher,et al.  Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma , 2008, Nature.

[14]  John M. Maris,et al.  Identification of ALK as a major familial neuroblastoma predisposition gene , 2008, Nature.

[15]  N. Crawford,et al.  Bromodomain 4 activation predicts breast cancer survival , 2008, Proceedings of the National Academy of Sciences.

[16]  Robert W. Williams,et al.  The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival , 2008, Clinical & Experimental Metastasis.

[17]  Joshua L. Deignan,et al.  Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. , 2008, Molecular genetics and metabolism.

[18]  A. Manira,et al.  Histone H2AX-dependent GABAA receptor regulation of stem cell proliferation , 2008, Nature.

[19]  J. Folkman,et al.  Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. , 2007, Cancer research.

[20]  W. Durante,et al.  ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION , 2007, Clinical and experimental pharmacology & physiology.

[21]  S. Snyder,et al.  Neuronal growth and survival mediated by eIF5A, a polyamine-modified translation initiation factor , 2007, Proceedings of the National Academy of Sciences.

[22]  A. Balmain,et al.  Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice , 2007, Nature.

[23]  Antonio Ortega,et al.  Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. , 2006, Journal of the National Cancer Institute.

[24]  A. Balmain,et al.  Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Bruce T Lahn,et al.  Trak1 mutation disrupts GABAA receptor homeostasis in hypertonic mice , 2006, Nature Genetics.

[26]  Isabelle Janoueix-Lerosey,et al.  Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. , 2005, Cancer letters.

[27]  P. Pharoah,et al.  Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1 , 2005, Nature Genetics.

[28]  M. Mori,et al.  GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  E. Rappaport,et al.  Germline PHOX2B mutation in hereditary neuroblastoma. , 2004, American journal of human genetics.

[30]  E. Gerner,et al.  Polyamines and cancer: old molecules, new understanding , 2004, Nature Reviews Cancer.

[31]  A. Contestabile,et al.  Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation , 2004, Journal of Cell Science.

[32]  W. Grody,et al.  Widespread Expression of Arginase I in Mouse Tissues: Biochemical and Physiological Implications , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  Ajay N. Jain,et al.  Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. , 2003, Cancer research.

[34]  Hiroki Nagase,et al.  Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human , 2003, Nature Genetics.

[35]  Hao Wu,et al.  R/qtl: QTL Mapping in Experimental Crosses , 2003, Bioinform..

[36]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[37]  W. Grody,et al.  Arginase expression in mouse embryonic development , 2002, Mechanisms of Development.

[38]  Ching Yu Austin Huang,et al.  SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery. , 2002, BioTechniques.

[39]  L. Kruglyak,et al.  Genetic Dissection of Transcriptional Regulation in Budding Yeast , 2002, Science.

[40]  Albert-László Barabási,et al.  Genetic Dissection of Transcriptional Regulation in Budding Yeast , 2002 .

[41]  W. Grody,et al.  Expression of arginase isozymes in mouse brain , 2001, Journal of neuroscience research.

[42]  T. M. Hsu,et al.  Universal SNP genotyping assay with fluorescence polarization detection. , 2001, BioTechniques.

[43]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Cederbaum,et al.  Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. , 2000, Cancer research.

[45]  Xiaohui He,et al.  Pharmacophore/Receptor Models for GABAA/BzR Subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a Comprehensive Ligand-Mapping Approach , 2000 .

[46]  R. Mckernan,et al.  Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. , 2000, Journal of medicinal chemistry.

[47]  R. Mckernan,et al.  Pharmacophore/receptor models for GABA(A)/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes. , 2000, Drug design and discovery.

[48]  J. Boucher,et al.  Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. , 1999, Nitric oxide : biology and chemistry.

[49]  G. Mohapatra,et al.  Targeted expression of MYCN causes neuroblastoma in transgenic mice , 1997, The EMBO journal.

[50]  Arthur M Buchberg,et al.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.

[51]  P Rhodes,et al.  Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Hale,et al.  Impact of gender on the natural history of neuroblastoma. , 1994, Pediatric hematology and oncology.

[53]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Macdonald,et al.  Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture , 1991, Epilepsy Research.

[55]  A. Guidotti,et al.  Cloning and expression of cDNA for human diazepam binding inhibitor, a natural ligand of an allosteric regulatory site of the gamma-aminobutyric acid type A receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Trent,et al.  Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc , 1984, Nature.

[57]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.